Tags

Type your tag names separated by a space and hit enter

Value and utility of 532 nanometre pulsed potassium-titanyl-phosphate laser in endoscopic laryngeal surgery.
J Laryngol Otol. 2010 Apr; 124(4):407-11.JL

Abstract

OBJECTIVES

Recently, the 532 nm pulsed potassium-titanyl-phosphate laser has emerged as an effective angiolytic laser for treating mucosal lesions of the larynx in the operating theatre and clinic. We sought to assess the current impact of potassium-titanyl-phosphate laser on our laryngeal surgery practice.

STUDY DESIGN

Retrospective review of 710 patients undergoing endoscopic laryngeal surgery over a one-year period.

METHODS

Medical records of the endoscopic laryngeal procedures were reviewed; 386/710 had been performed in the clinic and 324/710 in the operating theatre under general anaesthesia. Indications for the procedures were classified by pathology.

RESULTS

Pulsed potassium-titanyl-phosphate laser was used in 209/386 clinic procedures. The indications for these procedures were: dysplasia (114/209 procedures), papillomatosis (89/209), varices or ectasia (three of 209), and 'other' (three of 209). Pulsed potassium-titanyl-phosphate laser was used in 178/324 operating theatre endoscopic laryngeal procedures. The indications for these procedures were: cancer (54/178 procedures), dysplasia (52/178), papillomatosis (38/178), varices or ectasia (13/178), polyps (six of 178), nodules (six of 178), stenosis (five of 178), granulation (three of 178), and amyloid (one of 178).

CONCLUSIONS

Due to its versatility, the 532 nm pulsed potassium-titanyl-phosphate laser is our most commonly utilised instrument for performing endoscopic laryngeal surgery.

Authors+Show Affiliations

Department of Surgery, Center for Laryngeal Surgery and Voice Rehabilitation, Massachusetts General Hospital, Harvard Medical School, One Bowdoin Square, 11th Floor, Boston, MA 02114, USA. burns.james@mgh.harvard.eduNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

19941682

Citation

Burns, J A., et al. "Value and Utility of 532 Nanometre Pulsed Potassium-titanyl-phosphate Laser in Endoscopic Laryngeal Surgery." The Journal of Laryngology and Otology, vol. 124, no. 4, 2010, pp. 407-11.
Burns JA, Friedman AD, Lutch MJ, et al. Value and utility of 532 nanometre pulsed potassium-titanyl-phosphate laser in endoscopic laryngeal surgery. J Laryngol Otol. 2010;124(4):407-11.
Burns, J. A., Friedman, A. D., Lutch, M. J., Hillman, R. E., & Zeitels, S. M. (2010). Value and utility of 532 nanometre pulsed potassium-titanyl-phosphate laser in endoscopic laryngeal surgery. The Journal of Laryngology and Otology, 124(4), 407-11. https://doi.org/10.1017/S0022215109991824
Burns JA, et al. Value and Utility of 532 Nanometre Pulsed Potassium-titanyl-phosphate Laser in Endoscopic Laryngeal Surgery. J Laryngol Otol. 2010;124(4):407-11. PubMed PMID: 19941682.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Value and utility of 532 nanometre pulsed potassium-titanyl-phosphate laser in endoscopic laryngeal surgery. AU - Burns,J A, AU - Friedman,A D, AU - Lutch,M J, AU - Hillman,R E, AU - Zeitels,S M, Y1 - 2009/11/27/ PY - 2009/11/28/entrez PY - 2009/11/28/pubmed PY - 2010/5/26/medline SP - 407 EP - 11 JF - The Journal of laryngology and otology JO - J Laryngol Otol VL - 124 IS - 4 N2 - OBJECTIVES: Recently, the 532 nm pulsed potassium-titanyl-phosphate laser has emerged as an effective angiolytic laser for treating mucosal lesions of the larynx in the operating theatre and clinic. We sought to assess the current impact of potassium-titanyl-phosphate laser on our laryngeal surgery practice. STUDY DESIGN: Retrospective review of 710 patients undergoing endoscopic laryngeal surgery over a one-year period. METHODS: Medical records of the endoscopic laryngeal procedures were reviewed; 386/710 had been performed in the clinic and 324/710 in the operating theatre under general anaesthesia. Indications for the procedures were classified by pathology. RESULTS: Pulsed potassium-titanyl-phosphate laser was used in 209/386 clinic procedures. The indications for these procedures were: dysplasia (114/209 procedures), papillomatosis (89/209), varices or ectasia (three of 209), and 'other' (three of 209). Pulsed potassium-titanyl-phosphate laser was used in 178/324 operating theatre endoscopic laryngeal procedures. The indications for these procedures were: cancer (54/178 procedures), dysplasia (52/178), papillomatosis (38/178), varices or ectasia (13/178), polyps (six of 178), nodules (six of 178), stenosis (five of 178), granulation (three of 178), and amyloid (one of 178). CONCLUSIONS: Due to its versatility, the 532 nm pulsed potassium-titanyl-phosphate laser is our most commonly utilised instrument for performing endoscopic laryngeal surgery. SN - 1748-5460 UR - https://www.unboundmedicine.com/medline/citation/19941682/Value_and_utility_of_532_nanometre_pulsed_potassium_titanyl_phosphate_laser_in_endoscopic_laryngeal_surgery_ DB - PRIME DP - Unbound Medicine ER -